Sign In

Igor Serov

Co-founder, CFO at Hemoglobin Oxygen Therapeutics LLC

Igor Serov is the Chief Financial Officer (CFO) and a co-founder of HbO2 Therapeutics, a company specializing in the development of hemoglobin-based oxygen carriers for both human and veterinary applications. He has over 20 years of experience in the investment banking sector, having held various leadership roles primarily in London, where he managed capital markets and other financial groups.15

Serov's role at HbO2 Therapeutics involves overseeing the company's financial strategies and operations, contributing to its mission to advance innovative therapies that address critical medical needs.23 His background in finance complements the scientific and operational expertise of the team at HbO2 Therapeutics, positioning the company as a leader in its field.15

In addition to his current position, Serov has a history of involvement in various business development initiatives and partnerships within the healthcare sector, which enhances his effectiveness in driving the company's growth and financial health.46

Related Questions

What are Igor Serov's main responsibilities at HbO2 Therapeutics?
How did Igor Serov transition from investment banking to biotech?
What are some notable achievements of Igor Serov in his career?
How has Igor Serov's experience at Sberbank influenced his role at HbO2 Therapeutics?
What are the future plans for HbO2 Therapeutics under Igor Serov's leadership?
Igor Serov
Igor Serov, photo 1
Igor Serov, photo 2
Add to my network

Location

Waltham, Massachusetts, United States